270 related articles for article (PubMed ID: 27760769)
1. A small molecule screening to detect potential therapeutic targets in human podocytes.
Widmeier E; Tan W; Airik M; Hildebrandt F
Am J Physiol Renal Physiol; 2017 Jan; 312(1):F157-F171. PubMed ID: 27760769
[TBL] [Abstract][Full Text] [Related]
2. DAAM2 Variants Cause Nephrotic Syndrome via Actin Dysregulation.
Schneider R; Deutsch K; Hoeprich GJ; Marquez J; Hermle T; Braun DA; Seltzsam S; Kitzler TM; Mao Y; Buerger F; Majmundar AJ; Onuchic-Whitford AC; Kolvenbach CM; Schierbaum L; Schneider S; Halawi AA; Nakayama M; Mann N; Connaughton DM; Klämbt V; Wagner M; Riedhammer KM; Renders L; Katsura Y; Thumkeo D; Soliman NA; Mane S; Lifton RP; Shril S; Khokha MK; Hoefele J; Goode BL; Hildebrandt F
Am J Hum Genet; 2020 Dec; 107(6):1113-1128. PubMed ID: 33232676
[TBL] [Abstract][Full Text] [Related]
3. Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome.
Kitzler TM; Kachurina N; Bitzan MM; Torban E; Goodyer PR
Pediatr Nephrol; 2018 Oct; 33(10):1741-1750. PubMed ID: 29982877
[TBL] [Abstract][Full Text] [Related]
4.
Hermle T; Schneider R; Schapiro D; Braun DA; van der Ven AT; Warejko JK; Daga A; Widmeier E; Nakayama M; Jobst-Schwan T; Majmundar AJ; Ashraf S; Rao J; Finn LS; Tasic V; Hernandez JD; Bagga A; Jalalah SM; El Desoky S; Kari JA; Laricchia KM; Lek M; Rehm HL; MacArthur DG; Mane S; Lifton RP; Shril S; Hildebrandt F
J Am Soc Nephrol; 2018 Aug; 29(8):2123-2138. PubMed ID: 29959197
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of Crb2 in podocytes expands a variation of CRB2 mutations in steroid-resistant nephrotic syndrome.
Udagawa T; Jo T; Yanagihara T; Shimizu A; Mitsui J; Tsuji S; Morishita S; Onai R; Miura K; Kanda S; Kajiho Y; Tsurumi H; Oka A; Hattori M; Harita Y
Pediatr Nephrol; 2017 May; 32(5):801-809. PubMed ID: 27942854
[TBL] [Abstract][Full Text] [Related]
6. [Role of podocyte injury signaling pathway in steroid-resistant nephrotic syndrome and research progress in traditional Chinese medicine intervention].
Yu WX; Yan W; Dai EL; Tian WX; Dang WJ
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3246-3254. PubMed ID: 37382008
[TBL] [Abstract][Full Text] [Related]
7. Advillin acts upstream of phospholipase C ϵ1 in steroid-resistant nephrotic syndrome.
Rao J; Ashraf S; Tan W; van der Ven AT; Gee HY; Braun DA; Fehér K; George SP; Esmaeilniakooshkghazi A; Choi WI; Jobst-Schwan T; Schneider R; Schmidt JM; Widmeier E; Warejko JK; Hermle T; Schapiro D; Lovric S; Shril S; Daga A; Nayir A; Shenoy M; Tse Y; Bald M; Helmchen U; Mir S; Berdeli A; Kari JA; El Desoky S; Soliman NA; Bagga A; Mane S; Jairajpuri MA; Lifton RP; Khurana S; Martins JC; Hildebrandt F
J Clin Invest; 2017 Dec; 127(12):4257-4269. PubMed ID: 29058690
[TBL] [Abstract][Full Text] [Related]
8. Salvianolic acid A attenuates steroid resistant nephrotic syndrome through suPAR/uPAR-αvβ3 signaling Inhibition.
Li X; Qi D; Wang MY; Ji K; Xie QL; Wang Y; Du SH; Fan HY
J Ethnopharmacol; 2021 Oct; 279():114351. PubMed ID: 34157324
[TBL] [Abstract][Full Text] [Related]
9. Hiding in plain sight: genetics of childhood steroid-resistant nephrotic syndrome in Sub-Saharan Africa.
Williams AE; Esezobor CI; Lane BM; Gbadegesin RA
Pediatr Nephrol; 2023 Jul; 38(7):2003-2012. PubMed ID: 36459247
[TBL] [Abstract][Full Text] [Related]
10. The glomerular permeability factors in idiopathic nephrotic syndrome.
Davin JC
Pediatr Nephrol; 2016 Feb; 31(2):207-15. PubMed ID: 25925039
[TBL] [Abstract][Full Text] [Related]
11. Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism.
Lin L; Ye Y; Fu H; Gu W; Zhao M; Sun J; Cao Z; Huang G; Xie Y; Liu F; Li L; Li Q; Mao J; Hu L
Cell Commun Signal; 2023 Nov; 21(1):324. PubMed ID: 37957688
[TBL] [Abstract][Full Text] [Related]
12. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.
Ashraf S; Gee HY; Woerner S; Xie LX; Vega-Warner V; Lovric S; Fang H; Song X; Cattran DC; Avila-Casado C; Paterson AD; Nitschké P; Bole-Feysot C; Cochat P; Esteve-Rudd J; Haberberger B; Allen SJ; Zhou W; Airik R; Otto EA; Barua M; Al-Hamed MH; Kari JA; Evans J; Bierzynska A; Saleem MA; Böckenhauer D; Kleta R; El Desoky S; Hacihamdioglu DO; Gok F; Washburn J; Wiggins RC; Choi M; Lifton RP; Levy S; Han Z; Salviati L; Prokisch H; Williams DS; Pollak M; Clarke CF; Pei Y; Antignac C; Hildebrandt F
J Clin Invest; 2013 Dec; 123(12):5179-89. PubMed ID: 24270420
[TBL] [Abstract][Full Text] [Related]
13. WT1 and NPHS2 gene mutation analysis and clinical management of steroid-resistant nephrotic syndrome.
Ramanathan AS; Vijayan M; Rajagopal S; Rajendiran P; Senguttuvan P
Mol Cell Biochem; 2017 Feb; 426(1-2):177-181. PubMed ID: 27885584
[TBL] [Abstract][Full Text] [Related]
14. A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules.
Lee HW; Khan SQ; Faridi MH; Wei C; Tardi NJ; Altintas MM; Elshabrawy HA; Mangos S; Quick KL; Sever S; Reiser J; Gupta V
J Am Soc Nephrol; 2015 Nov; 26(11):2741-52. PubMed ID: 25858967
[TBL] [Abstract][Full Text] [Related]
15. Genetic testing in steroid-resistant nephrotic syndrome: when and how?
Lovric S; Ashraf S; Tan W; Hildebrandt F
Nephrol Dial Transplant; 2016 Nov; 31(11):1802-1813. PubMed ID: 26507970
[TBL] [Abstract][Full Text] [Related]
16. Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how?
Preston R; Stuart HM; Lennon R
Pediatr Nephrol; 2019 Feb; 34(2):195-210. PubMed ID: 29181713
[TBL] [Abstract][Full Text] [Related]
17. Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome.
Braun DA; Sadowski CE; Kohl S; Lovric S; Astrinidis SA; Pabst WL; Gee HY; Ashraf S; Lawson JA; Shril S; Airik M; Tan W; Schapiro D; Rao J; Choi WI; Hermle T; Kemper MJ; Pohl M; Ozaltin F; Konrad M; Bogdanovic R; Büscher R; Helmchen U; Serdaroglu E; Lifton RP; Antonin W; Hildebrandt F
Nat Genet; 2016 Apr; 48(4):457-65. PubMed ID: 26878725
[TBL] [Abstract][Full Text] [Related]
18. NUP133 Controls Nuclear Pore Assembly, Transcriptome Composition, and Cytoskeleton Regulation in Podocytes.
Rogg M; Maier JI; Ehle M; Sammarco A; Schilling O; Werner M; Schell C
Cells; 2022 Apr; 11(8):. PubMed ID: 35455939
[TBL] [Abstract][Full Text] [Related]
19. COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness.
Heeringa SF; Chernin G; Chaki M; Zhou W; Sloan AJ; Ji Z; Xie LX; Salviati L; Hurd TW; Vega-Warner V; Killen PD; Raphael Y; Ashraf S; Ovunc B; Schoeb DS; McLaughlin HM; Airik R; Vlangos CN; Gbadegesin R; Hinkes B; Saisawat P; Trevisson E; Doimo M; Casarin A; Pertegato V; Giorgi G; Prokisch H; Rötig A; Nürnberg G; Becker C; Wang S; Ozaltin F; Topaloglu R; Bakkaloglu A; Bakkaloglu SA; Müller D; Beissert A; Mir S; Berdeli A; Varpizen S; Zenker M; Matejas V; Santos-Ocaña C; Navas P; Kusakabe T; Kispert A; Akman S; Soliman NA; Krick S; Mundel P; Reiser J; Nürnberg P; Clarke CF; Wiggins RC; Faul C; Hildebrandt F
J Clin Invest; 2011 May; 121(5):2013-24. PubMed ID: 21540551
[TBL] [Abstract][Full Text] [Related]
20. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.
Gee HY; Zhang F; Ashraf S; Kohl S; Sadowski CE; Vega-Warner V; Zhou W; Lovric S; Fang H; Nettleton M; Zhu JY; Hoefele J; Weber LT; Podracka L; Boor A; Fehrenbach H; Innis JW; Washburn J; Levy S; Lifton RP; Otto EA; Han Z; Hildebrandt F
J Clin Invest; 2015 Jun; 125(6):2375-84. PubMed ID: 25961457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
